Ex parte SHAH - Page 3




              Appeal No. 1996-2731                                                                                     
              Application No. 08/240,862                                                                               

              components and concentrations listed on page 9 and Table I of the specification.  The                    
              examiner also withdrew the final rejection of claims 1-18 under 35 U.S.C. § 112, second                  
              paragraph, as being indefinite for failing to particularly point out and distinctly claim the            
              subject matter which applicant regards as the invention with respect to the phrases “[a]ctive            
              ingredients” and “consisting essentially of”.  See, Examiner’s Answer (Paper No. 12,                     
              mailed September 25, 1995), page 3.  The remaining issue on appeal is the rejection of                   
              claims 3, 5, 6, 8, 9, 12 and 21-23 under 35 U.S.C. § 103 as being unpatentable over Maes,                
              Brooks and Syed.  We reverse.                                                                            


                                                    DISCUSSION                                                         
                     In reaching our decision in this appeal, we have given careful consideration to the               
              appellant's specification and claims, and to the respective positions articulated by the                 
              appellant and the examiner.  We make reference to the Examiner’s Answer for the                          
              examiner’s reasoning in support of the rejection.  We further reference appellant’s Brief                
              (Paper No. 11, filed September 11, 1995) for the appellant’s arguments in favor of                       
              patentability.                                                                                           









                                                          3                                                            





Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007